You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 9, September 2, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Revascularization
 •Cardiovascular System
 •Surgery
 •Surgical Interventions
 •Cardiovascular/ Cardiothoracic Surgery
 •Prognosis/ Outcomes
 •Arrhythmias
 •Cardiovascular Disease/ Myocardial Infarction
 •Cardiovascular Intervention
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prognostic Importance of Ventricular Arrhythmia in Patients Treated With Percutaneous Coronary Intervention

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The study by Dr Mehta and colleagues1 supports the prognostic importance of ventricular tachycardia or ventricular fibrillation (VT/VF) as an independent predictor of early mortality in patients with ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention. Although the authors warned about the limitations of the study, we believe that not considering left ventricular ejection fraction (LVEF) among the predictors of mortality in the multivariable models represents a serious limitation that hinders the interpretation of these data. Left ventricular ejection fraction is a strong predictor of mortality in patients with STEMI,2 and assessing the prognostic value of other covariates without correcting for LVEF may lead to unreliable results. Since there is no adjustment for LVEF, the results of this study may lead to the conclusion that patients who have a preserved LVEF and experience VT/VF, mostly during catheterization, have a 3-fold increase of mortality compared with . . . [Full Text of this Article]

Tullio Palmerini, MD
tulliopalmerini@hotmail.com
Istituto di Cardiologia
Università di Bologna
Bologna, Italy

Stefano De Servi, MD
Dipartimento di Malattie Cardiovascolari
Ospedale Civile
Legnano, Italy

Angelo Branzi, MD
Istituto di Cardiologia
Università di Bologna



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Incidence of and Outcomes Associated With Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention
Rajendra H. Mehta, Aijing Z. Starr, Renato D. Lopes, Judith S. Hochman, Petr Widimsky, Karen S. Pieper, Paul W. Armstrong, Christopher B. Granger, and for the APEX AMI Investigators
JAMA. 2009;301(17):1779-1789.
ABSTRACT | FULL TEXT  

RELATED LETTER

Prognostic Importance of Ventricular Arrhythmia in Patients Treated With Percutaneous Coronary Intervention—Reply
Rajendra H. Mehta, Paul W. Armstrong, and Christopher B. Granger
JAMA. 2009;302(9):944-945.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.